2018
DOI: 10.1007/s12105-018-0891-9
|View full text |Cite
|
Sign up to set email alerts
|

Ear and Temporal Bone Pathology: Neural, Sclerosing and Myofibroblastic Lesions

Abstract: Neural, sclerosing, and myofibroblastic lesions of the ear and temporal bone present diagnostic challenges for both clinicians and pathologists due to significant overlap in their clinical presentations, histologic appearances, and immunohistochemical profiles. While some of these lesions, such as schwannomas, are relatively common, others are rendered even more difficult because they are encountered very rarely in routine surgical pathology practice. This review is intended to provide an update on the patholo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
0
3

Year Published

2019
2019
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(8 citation statements)
references
References 61 publications
0
5
0
3
Order By: Relevance
“…CD34 is a characteristically overexpressed antigen in SFTs [ 16 ], though it can be lost in some malignant SFTs [ 17 ]. Significant number of cases show also a CD99 and B-cell lymphoma protein 2 (Bcl-2) positivity, but are usually negative for S-100, desmin, nuclear β-catenins, cytokeratins and other muscular, vascular, neural and epithelial markers [ 8 , 9 , 13 , 17 , 18 ]. Immunohistochemical analysis distinguishes these tumors from other microscopically similar spindle-cell and mesenchymal neoplasms that also can be found in the external auditory meatus, such as schwannoma or fibroma [ 6 , 16 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…CD34 is a characteristically overexpressed antigen in SFTs [ 16 ], though it can be lost in some malignant SFTs [ 17 ]. Significant number of cases show also a CD99 and B-cell lymphoma protein 2 (Bcl-2) positivity, but are usually negative for S-100, desmin, nuclear β-catenins, cytokeratins and other muscular, vascular, neural and epithelial markers [ 8 , 9 , 13 , 17 , 18 ]. Immunohistochemical analysis distinguishes these tumors from other microscopically similar spindle-cell and mesenchymal neoplasms that also can be found in the external auditory meatus, such as schwannoma or fibroma [ 6 , 16 ].…”
Section: Discussionmentioning
confidence: 99%
“…Immunohistochemical analysis distinguishes these tumors from other microscopically similar spindle-cell and mesenchymal neoplasms that also can be found in the external auditory meatus, such as schwannoma or fibroma [ 6 , 16 ]. Benign fibrous histiocytoma, sarcomatoid carcinoma as well as well-vascularized pathologies like vascular malformation, vascular metastasis, angiosarcoma, high-grade sarcoma or venous varix also have to be excluded [ 18 , 19 ]. The Ki-67 marker can be used to assess the proliferation rate [ 20 ].…”
Section: Discussionmentioning
confidence: 99%
“…[5][6][7] Muitas vezes este tipo de tumor é erroneamente diagnosticado como outros tumores mais comuns da cabeça e pescoço, como o angiofibroma, no entanto apresenta características histológicas e imuno-histoquímicas diferenciadoras. 7 As características microscópicas levam à suspeição do diagnóstico de TFS, em particular pela observação de células fusiformes ou ovais, dispostas num padrão aleatório, com alternância de áreas constituídas essencialmente por colagénio e áreas hipercelulares, 10 mas não são suficientes por si só para diferenciar o TFS de outros tumores benignos de tecidos moles, como perineuromas, lipomas de células fusiformes, fibromatose desmoide e sarcomas de células fusiformes. 10,11 Antigamente o TFS era classificado como hemangiopericitoma, mas pelo facto do primeiro ter uma origem fibroblástica e não pericítica, estas são hoje classificadas como diferentes entidades.…”
Section: Discussionunclassified
“…7 As características microscópicas levam à suspeição do diagnóstico de TFS, em particular pela observação de células fusiformes ou ovais, dispostas num padrão aleatório, com alternância de áreas constituídas essencialmente por colagénio e áreas hipercelulares, 10 mas não são suficientes por si só para diferenciar o TFS de outros tumores benignos de tecidos moles, como perineuromas, lipomas de células fusiformes, fibromatose desmoide e sarcomas de células fusiformes. 10,11 Antigamente o TFS era classificado como hemangiopericitoma, mas pelo facto do primeiro ter uma origem fibroblástica e não pericítica, estas são hoje classificadas como diferentes entidades. A presença de áreas hipocelulares preenchidas de forma densa por colagénio e a imunorreatividade ao CD34 distinguem o TFS do hemangiopericitoma.…”
Section: Discussionunclassified
“…It has been reported to have relatively high incidence of local recurrence (>50% of cases), metastasis (40-80% of cases) and tumor-related mortality (2,3). SEF typically involves the extremities or the torso (2), followed by the abdominal viscera (4,5) and head and neck areas (6)(7)(8). Primary SEF in the bone was first reported in 2001 (9).…”
Section: Introductionmentioning
confidence: 99%